Although I am glad they finally moved on this one and got something going, not so sure about the target company (maybe the board felt pressured to move quickly given the new -and pending- ASX rules relating to RTO's?). Smells a bit like the key players are looking after themselves and get set quickly before (all) the rule changes come into effect. Not much potential for short term sp increases with this one given the BCAL Dx is merely in proof of concept stage. Larger clinical studies take time and before you get to approved products, if ever, years will go by. This is going to be a very, very long road imo.
Although I am glad they finally moved on this one and got...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $47.56M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $16.23K | 1.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 10253909 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 2705842 | 9 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| SPX (ASX) Chart |
